Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Galegine hydrochloride, a guanidine derivative derived from G. officinalis, plays a role in inducing weight loss in mice and has contributed to the development of biguanides, including metformin and phenformin. This compound stimulates AMPK activation in 3T3-L1 adipocytes, L6 myotubes, H4IIE rat hepatoma, and HEK293 human kidney cell lines. Additionally, galegine hydrochloride exhibits antibacterial properties, particularly demonstrating a minimum inhibitory concentration of 4 mg/L against Staphylococcus aureus strains[1][2].
説明 | Galegine hydrochloride, a guanidine derivative derived from G. officinalis, plays a role in inducing weight loss in mice and has contributed to the development of biguanides, including metformin and phenformin. This compound stimulates AMPK activation in 3T3-L1 adipocytes, L6 myotubes, H4IIE rat hepatoma, and HEK293 human kidney cell lines. Additionally, galegine hydrochloride exhibits antibacterial properties, particularly demonstrating a minimum inhibitory concentration of 4 mg/L against Staphylococcus aureus strains[1][2]. |
In vitro | Pre-treatment with Galegine hydrochloride (10 μM-3 mM; 5 h) enhances insulin-independent glucose absorption in 3T3-L1 adipocytes concentration-dependently, without impacting cell health. Similarly, incubation (1 μM-1 mM, 5 h) boosts glucose intake in L6 myotubes without affecting viability[1]. Galegine hydrochloride (0.3-300 μM; 24 hours) slightly decreases basal glycerol release and significantly reduces isoprenaline-induced glycerol release in 3T3-L1 adipocytes. In H4IIE rat hepatoma cells, Galegine hydrochloride (10 or 300 μM) up to 6 hours progressively activates AMPK, reaching peak activation at 360 min and maintaining twofold activation at 24 hours with 300 μM, showing a stronger effect at 300 μM than at 10 μM. A one-hour incubation triggers concentration-dependent AMPK activation in both 3T3L-1 adipocytes and L-6 myotubes, as well as in a human kidney cell line (HEK293)[1]. |
In vivo | Galegine hydrochloride (63 mg/kg; feed; daily for 11 days) produces a significant reduction in body weight[1]. |
分子量 | 163.65 |
分子式 | C6H14ClN3 |
CAS No. | 2368870-39-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 5.2 mg/mL (31.78 mM)
H2O: 43.33 mg/mL (264.77 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Galegine hydrochloride 2368870-39-5 Galegine Hydrochloride Inhibitor inhibitor inhibit